Understanding Pediatric Stroke: Etiology, Diagnosis, and Management in Children Under 15 Years

Dana AlZamer1, Yazan S Al-Zamer2,3, Majeed Al-Khafaji4

  • 1Family Medicine, Jordan University of Science and Technology, Irbid, JOR.

Cureus
|March 16, 2026
PubMed

Insights

Pediatric stroke, though rare, presents significant risks. Key causes include cardioembolic sources, vascular issues, and hypercoagulable states, requiring early recognition and tailored interventions for better outcomes.

Area of Science:

  • Neurology
  • Pediatrics
  • Vascular Medicine

Background:

  • Stroke in children under 15 is uncommon but leads to severe mortality and neurological disability.
  • Understanding causes, diagnosis, and management is vital for improving pediatric stroke outcomes.

Purpose of the Study:

  • To review current literature on the etiology, diagnosis, and management of stroke in children aged 15 years or younger.
  • To summarize recent evidence, focusing on management and therapeutic strategies.

Main Methods:

  • Comprehensive literature review of PubMed, Scopus, and Google Scholar (1997-2023).
  • Inclusion of peer-reviewed articles specifically on pediatric stroke (patients <15 years).
  • Exclusion of adult stroke studies; focus on recent management evidence.

Main Results:

  • Ischemic stroke etiologies: cardioembolic sources, vascular abnormalities, hypercoagulable states, infections.
  • Hemorrhagic stroke causes: trauma, aneurysms, coagulopathies.
  • Advanced imaging (MRI, MR angiography) improves diagnosis but has limited access in resource-poor areas.

Conclusions:

  • Pediatric stroke is a rare, challenging condition with diverse causes and presentations.
  • Limited pediatric-specific evidence complicates management and thrombolysis applicability.
  • Early recognition, intervention, and future research into targeted therapies are crucial.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
687